BioSpace News Archive

Business

AlloVir Appoints Derek Adams, Ph.D., to Board of Directors

AlloVir (Nasdaq: ALVR), a late-clinical stage allogeneic T cell immunotherapy company, today announced the appointment of Derek Adams, Ph.D., to its Board of Directors, effective March 1, 2023.

February 23, 2023
·
5 min read
Cingulate Announces Positive Top-Line Results from Fed/Fast Study of Lead Asset CTx-1301 for ADHD

Cingulate Inc. today announced positive top-line results from the CTx-1301-003 study.

February 23, 2023
·
8 min read
Business

Generation Bio Outlines 2023 Strategic Priorities and Reports Fourth Quarter and Full Year 2022 Financial Results

Generation Bio Co outlined its strategic priorities for 2023 and reported fourth quarter and full year 2022 financial results.

February 23, 2023
·
7 min read
Drug Development

Nektar Therapeutics Announces Phase 2 Topline Data for Rezpegaldesleukin in Patients with Systemic Lupus Erythematosus

Nektar Therapeutics (Nasdaq: NKTR) today announced topline data from a Phase 2 randomized, double-blind, placebo-controlled study of rezpegaldesleukin.

February 23, 2023
·
10 min read
Business

Apollo Medical Holdings, Inc. Reports Fourth Quarter and Year-End 2022 Results

Apollo Medical Holdings, Inc. today announced its consolidated financial results for the fourth quarter and year ended December 31, 2022.

February 23, 2023
·
20 min read
Deals

Enliven Therapeutics Closes Merger with Imara and Private Placement of $165 Million

Enliven Therapeutics, Inc. (Enliven) (Nasdaq: ELVN), a clinical-stage precision oncology company focused on the discovery and development of next-generation small molecule kinase inhibitors, today announced the completion of its previously announced merger.

February 23, 2023
·
7 min read
Accelerating Innovation for the Spinal Cord Injury Community

Praxis Spinal Cord Institute is pleased to announce the three transformative technologies selected as the SCI Incubate program cohort for 2023.

February 23, 2023
·
3 min read